Skip to content
November 9, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
The Trump Administration’s Global Health Pivot: A New Era of Foreign Aid Restructuring the-trump-administrations-global-health-pivot-a-new-era-of-foreign-aid-restructuring
  • Breast Cancer Legislation and Policy

The Trump Administration’s Global Health Pivot: A New Era of Foreign Aid Restructuring

Neng Nana October 8, 2026
As President Donald Trump embarks on his second term, his administration has moved with immediate and decisive...
Read More Read more about The Trump Administration’s Global Health Pivot: A New Era of Foreign Aid Restructuring
Navigating the Intersection: GLP-1 Medications and Breast Cancer Care navigating-the-intersection-glp-1-medications-and-breast-cancer-care
  • Survivorship and Post-Treatment

Navigating the Intersection: GLP-1 Medications and Breast Cancer Care

Raul Delapena Setiawan October 8, 2026
Written by Douglas Feil, NBCF Chief Program Officer Disclaimer: The information provided in this article is for...
Read More Read more about Navigating the Intersection: GLP-1 Medications and Breast Cancer Care
A Natural Evolution: The Rise of Autologous Fat Transfer in Post-Mastectomy Breast Reconstruction a-natural-evolution-the-rise-of-autologous-fat-transfer-in-post-mastectomy-breast-reconstruction
  • Breast Cancer Surgery and Reconstruction

A Natural Evolution: The Rise of Autologous Fat Transfer in Post-Mastectomy Breast Reconstruction

Raul Delapena Setiawan October 8, 2026
For decades, the standard path for women undergoing breast reconstruction following a mastectomy has been a binary...
Read More Read more about A Natural Evolution: The Rise of Autologous Fat Transfer in Post-Mastectomy Breast Reconstruction
The Twilight of a CRISPR Pioneer: Caribou Biosciences Seeks Strategic Alternatives Amid Financing Crisis the-twilight-of-a-crispr-pioneer-caribou-biosciences-seeks-strategic-alternatives-amid-financing-crisis
  • Chemotherapy and Targeted Therapy

The Twilight of a CRISPR Pioneer: Caribou Biosciences Seeks Strategic Alternatives Amid Financing Crisis

Neng Nana October 8, 2026
In a sobering development for the biotechnology sector, Caribou Biosciences—a CRISPR-focused firm co-founded by Nobel laureate Jennifer...
Read More Read more about The Twilight of a CRISPR Pioneer: Caribou Biosciences Seeks Strategic Alternatives Amid Financing Crisis
The Digital Renaissance: Transforming Archived Tissue into a Gateway for Ethical Drug Discovery the-digital-renaissance-transforming-archived-tissue-into-a-gateway-for-ethical-drug-discovery
  • Chemotherapy and Targeted Therapy

The Digital Renaissance: Transforming Archived Tissue into a Gateway for Ethical Drug Discovery

Muslim October 8, 2026
In the rapidly evolving landscape of preclinical research, a paradigm shift is underway. For decades, the pathology...
Read More Read more about The Digital Renaissance: Transforming Archived Tissue into a Gateway for Ethical Drug Discovery
Bridging the Gap: Tameron Harvell and the Future of Precision Oncology bridging-the-gap-tameron-harvell-and-the-future-of-precision-oncology-2
  • Metastatic Breast Cancer Research

Bridging the Gap: Tameron Harvell and the Future of Precision Oncology

Basiran October 8, 2026
In the rapidly shifting landscape of modern medicine, the intersection of patient advocacy, clinical expertise, and cutting-edge...
Read More Read more about Bridging the Gap: Tameron Harvell and the Future of Precision Oncology
A Rift in Global Health: Examining the Strained Relationship Between the United States and the WHO a-rift-in-global-health-examining-the-strained-relationship-between-the-united-states-and-the-who
  • Global Breast Cancer Awareness

A Rift in Global Health: Examining the Strained Relationship Between the United States and the WHO

Reynand Wu October 8, 2026
In a move that has sent tremors through the landscape of international diplomacy and global health security,...
Read More Read more about A Rift in Global Health: Examining the Strained Relationship Between the United States and the WHO
Bridging the Divide: New National Survey Reveals Urgent Call for Standardized Breast Cancer Care Across Canada bridging-the-divide-new-national-survey-reveals-urgent-call-for-standardized-breast-cancer-care-across-canada-3
  • Global Breast Cancer Awareness

Bridging the Divide: New National Survey Reveals Urgent Call for Standardized Breast Cancer Care Across Canada

Nana Wu October 8, 2026
Executive Summary: A Unified Vision for Patient Care A transformative shift in the Canadian healthcare landscape may...
Read More Read more about Bridging the Divide: New National Survey Reveals Urgent Call for Standardized Breast Cancer Care Across Canada
Unveiling a Cunning Cancer Strategy: How Triple-Negative Breast Cancer Recruits Nerves for Growth and Survival unveiling-a-cunning-cancer-strategy-how-triple-negative-breast-cancer-recruits-nerves-for-growth-and-survival
  • Medical Research and Clinical Trials

Unveiling a Cunning Cancer Strategy: How Triple-Negative Breast Cancer Recruits Nerves for Growth and Survival

Iffa Jayyana October 7, 2026
OKLAHOMA CITY, OK – In a significant breakthrough that redefines our understanding of aggressive cancers, new research...
Read More Read more about Unveiling a Cunning Cancer Strategy: How Triple-Negative Breast Cancer Recruits Nerves for Growth and Survival
ArriVent’s Firmonertinib Fails to Meet Primary Endpoint in NSCLC Trial, Stock Plummets Amidst Competitive Landscape arrivents-firmonertinib-fails-to-meet-primary-endpoint-in-nsclc-trial-stock-plummets-amidst-competitive-landscape
  • Medical Research and Clinical Trials

ArriVent’s Firmonertinib Fails to Meet Primary Endpoint in NSCLC Trial, Stock Plummets Amidst Competitive Landscape

Muslim October 7, 2026
A significant setback for ArriVent BioPharma has sent its stock price into a tailspin, following the disappointing...
Read More Read more about ArriVent’s Firmonertinib Fails to Meet Primary Endpoint in NSCLC Trial, Stock Plummets Amidst Competitive Landscape

Posts pagination

Previous 1 … 166 167 168 169 170 171 172 … 873 Next

Recent Posts

  • Unraveling the Paradox: Breakthrough Study Redefines Immunotherapy for Colorectal Cancer
  • Pregnancy complication indicator for risk of disease
  • Beyond the "Spaghetti": Talus Bio’s Structure-Free Revolution in Drug Discovery
  • A New Dawn in Genomic Medicine: Casgevy Now Available on the NHS for Blood Disorder Patients
  • The Missing Link: Why Your Mid-Back Strength Is the Secret to Longevity

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unraveling-the-paradox-breakthrough-study-redefines-immunotherapy-for-colorectal-cancer
  • Medical Research and Clinical Trials

Unraveling the Paradox: Breakthrough Study Redefines Immunotherapy for Colorectal Cancer

Reynand Wu November 8, 2026
pregnancy-complication-indicator-for-risk-of-disease
  • Medical Research and Clinical Trials

Pregnancy complication indicator for risk of disease

Siti Muinah November 8, 2026
beyond-the-spaghetti-talus-bios-structure-free-revolution-in-drug-discovery
  • Treatment Innovations

Beyond the "Spaghetti": Talus Bio’s Structure-Free Revolution in Drug Discovery

Reynand Wu November 8, 2026
a-new-dawn-in-genomic-medicine-casgevy-now-available-on-the-nhs-for-blood-disorder-patients
  • Genomics and Precision Medicine

A New Dawn in Genomic Medicine: Casgevy Now Available on the NHS for Blood Disorder Patients

Ammar Sabilarrohman November 8, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.